The multifaceted role of extracellular vesicles in prostate cancer-a review.

IF 4.6 Q1 ONCOLOGY 癌症耐药(英文) Pub Date : 2023-07-28 eCollection Date: 2023-01-01 DOI:10.20517/cdr.2023.17
Divya Prakash Jain, Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Rupshee Jain, Vikas Jain
{"title":"The multifaceted role of extracellular vesicles in prostate cancer-a review.","authors":"Divya Prakash Jain,&nbsp;Yirivinti Hayagreeva Dinakar,&nbsp;Hitesh Kumar,&nbsp;Rupshee Jain,&nbsp;Vikas Jain","doi":"10.20517/cdr.2023.17","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer is the second most prominent form of cancer in men and confers the highest mortality after lung cancer. The term \"extracellular vesicles\" refers to minute endosomal-derived membrane microvesicles and it was demonstrated that extracellular vesicles affect the environment in which tumors originate. Extracellular vesicles' involvement is also established in the development of drug resistance, angiogenesis, stemness, and radioresistance in various cancers including prostate cancer. Extracellular vesicles influence the general environment, processes, and growth of prostate cancer and can be a potential area that offers a significant lead in prostate cancer therapy. In this review, we have elaborated on the multifaceted role of extracellular vesicles in various processes involved in the development of prostate cancer, and their multitude of applications in the diagnosis and treatment of prostate cancer through the encapsulation of various bioactives.</p>","PeriodicalId":70759,"journal":{"name":"癌症耐药(英文)","volume":"6 3","pages":"481-498"},"PeriodicalIF":4.6000,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571058/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"癌症耐药(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20517/cdr.2023.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prostate cancer is the second most prominent form of cancer in men and confers the highest mortality after lung cancer. The term "extracellular vesicles" refers to minute endosomal-derived membrane microvesicles and it was demonstrated that extracellular vesicles affect the environment in which tumors originate. Extracellular vesicles' involvement is also established in the development of drug resistance, angiogenesis, stemness, and radioresistance in various cancers including prostate cancer. Extracellular vesicles influence the general environment, processes, and growth of prostate cancer and can be a potential area that offers a significant lead in prostate cancer therapy. In this review, we have elaborated on the multifaceted role of extracellular vesicles in various processes involved in the development of prostate cancer, and their multitude of applications in the diagnosis and treatment of prostate cancer through the encapsulation of various bioactives.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细胞外小泡在前列腺癌中的多方面作用——综述。
前列腺癌症是癌症在男性中第二突出的形式,其死亡率仅次于癌症。术语“细胞外小泡”是指微小的内涵体衍生的膜微泡,并且已经证明细胞外小囊泡影响肿瘤起源的环境。细胞外囊泡也参与了包括癌症在内的各种癌症的耐药性、血管生成、干燥和放射性耐药性的发展。细胞外囊泡影响癌症的一般环境、过程和生长,可能是一个潜在的领域,为癌症前列腺治疗提供了重要的指导。在这篇综述中,我们详细阐述了细胞外囊泡在参与前列腺癌症发展的各种过程中的多方面作用,以及它们通过封装各种生物活性物质在诊断和治疗癌症方面的广泛应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.60
自引率
0.00%
发文量
0
期刊最新文献
Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma. NFE2L2 and ferroptosis resistance in cancer therapy. The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models. Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategies. Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1